Dietary modifications for bowel dysfunction in rectal cancer survivors: The Altering Intake, Managing Symptoms (AIMS) intervention study.

Authors

null

Virginia Sun

City of Hope, Duarte, CA

Virginia Sun , Tracy E Crane , Samantha D Slack , Angela Yung , Sarah Wright , Stephen Sentovich , Kurt Melstrom , Marwan Fakih , Robert S. Krouse , Cynthia A. Thomson

Organizations

City of Hope, Duarte, CA, University of Arizona, Tucson, AZ, University of Pennsylvania, Philadelphia, PA

Research Funding

Other Foundation

Background: Rectal cancer survivors often experience persistent long-term effects of treatment. Functional deficits, such as bowel dysfunction, are associated with poor quality of life (QOL). There is a lack of evidence-based interventions to address bowel dysfunction symptoms in rectal cancer survivors. The purpose of this abstract is to describe the development and design of the Altering Intake, Managing Symptoms (AIMS) intervention to manage bowel dysfunction in rectal cancer survivors. Methods: Survivors with stage I-III rectosigmoid colon or rectal cancer who are 6 months post-treatment, > 21 years, and English-speaking are eligible to participate. The AIMS intervention is a ten (30-40 minute) session, 4 month, telephone-based intervention delivered by trained health coaches. Outcome measures are assessed at baseline, 4 and 6 months, and include the MSKCC Bowel Function Tool, the COH-QOL-CRC, and adherence to cancer survivorship diet guidelines. Results: Based on the Chronic Care Self-Management Model (CCM), the AIMS intervention applies social cognitive theory to improve self-efficacy and self-management of bowel symptoms by coaching survivors to modify their diets to attenuate symptoms and enhance diet quality. Motivational interviewing-based behavioral approaches are applied, such as goal setting, self-monitoring, identification of barriers, and problem-solving. Monitoring of diet health involves review of 24 hour dietary recalls in conjunction with food and symptom diaries to promote survivor-directed behavior change resulting in improved bowel health. Conclusions: The AIMS intervention is among the first and few to address diet behavior changes for symptom management in rectal cancer survivors. It has the potential to positively impact the quality of long-term rectal cancer survivorship by integrating classic behavior change theories for cancer symptom management. Findings from the study will inform the design and development of future multi-institutional Phase II and III randomized trials. Clinical trial information: NCT03063918

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2018 Cancer Survivorship Symposium

Session Type

Poster Session

Session Title

Poster Session B: Chronic Anticancer Therapy; Late- and Long-term Effects/Comorbitidities; Psychosocial Issues; Risk Assessment

Track

Care Coordination, Cost, and Education,Late- and Long-term Effects/Comorbidities,Health Promotion,Psychosocial Issues,Communication and Transitions,Risk Assessment,Chronic Anti-Cancer Therapy

Sub Track

Symptom Management

Clinical Trial Registration Number

NCT03063918

Citation

J Clin Oncol 36, 2018 (suppl 7S; abstr 141)

DOI

10.1200/JCO.2018.36.7_suppl.141

Abstract #

141

Poster Bd #

C6

Abstract Disclosures

Similar Abstracts

First Author: Eleonora Teplinsky

Abstract

2023 ASCO Annual Meeting

Yoga vs. behavioral placebo for fatigue and quality of life among older cancer survivors.

First Author: Evelyn Arana

Abstract

2023 ASCO Quality Care Symposium

Loss to primary care provider follow-up among survivors five to seven years post-diagnosis.

First Author: Alexandra G. Peluso